Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SOHO 2020 | Rise of antibody-based treatments in myeloma

Sagar Lonial, MD, FACP, Winship Cancer Institute of Emory University, Atlanta, GA, explores the rise of antibody-based treatment in multiple myeloma, including the approval of daratumumab, elotuzumab, and belantamab mafodotin. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).